Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IceCure Medical (ICCM) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for IceCure Medical (ICCM) over the last 5 years, with Q3 2025 value amounting to 2.17%.

  • IceCure Medical's Return on Capital Employed rose 7600.0% to 2.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.17%, marking a year-over-year increase of 7600.0%. This contributed to the annual value of 1.75% for FY2024, which is 9500.0% up from last year.
  • As of Q3 2025, IceCure Medical's Return on Capital Employed stood at 2.17%, which was up 7600.0% from 4.94% recorded in Q2 2025.
  • In the past 5 years, IceCure Medical's Return on Capital Employed ranged from a high of 4.94% in Q2 2025 and a low of 1.03% during Q3 2023
  • In the last 5 years, IceCure Medical's Return on Capital Employed had a median value of 0.0% in 2022 and averaged 0.74%.
  • In the last 5 years, IceCure Medical's Return on Capital Employed plummeted by -8400bps in 2023 and then surged by 36600bps in 2025.
  • IceCure Medical's Return on Capital Employed (Quarter) stood at 0.44% in 2021, then soared by 101bps to 0.0% in 2022, then surged by 28462bps to 1.11% in 2023, then surged by 68bps to 1.87% in 2024, then rose by 17bps to 2.17% in 2025.
  • Its Return on Capital Employed was 2.17% in Q3 2025, compared to 4.94% in Q2 2025 and 2.29% in Q1 2025.